Veracyte director plans sale of 7,500 shares
The notice identifies Morgan Stanley Smith Barney LLC as the broker and lists a cash-paid option exercise dated September 24, 2026.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
Veracyte, Inc. (VCYT) director Jens Holstein reported a proposed sale of 7,500 common shares with an aggregate market value of $352,500.00 and an approximate sale date of September 24, 2026. Morgan Stanley Smith Barney LLC is listed as the broker. The notice lists the shares as acquired from the issuer through a stock option exercise, with cash payment dated September 24, 2026. It also reports that Holstein sold 5,000 common shares for an aggregate market value of $204,747.00 on September 14, 2026, during the prior three months.
Key Figures
Key Terms
Rule 144 regulatory
Stock Option Exercise financial
person regulatory
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
AI-generated analysis. How Rhea-AI works. Not financial advice.